EU approves 5th COVID-19 vaccine for bloc, one by Novavax

12/20/2021 | by | Uncategorized

The European Union’s drugs regulator has given the green light to a fifth COVID-19 vaccine for use in the 27-nation bloc, granting conditional marketing authorization to the two-dose vaccine made by U.S. biotech company Novavax
Source: Test feed

Leave a Comment

Your email address will not be published.

*
*
*